In IDH-mutated gliomas, particularly diffuse astrocytomas and oligodendrogliomas, isocitrate dehydrogenase (IDH) metabolism is altered with the production of the oncometabolite 2-hydroxyglutarate (2-HG). Here, IDH1 is linked to glioma.